Pancreatic Cancer Recurrence in the Netherlands

Summary

The aim of this nationwide, observational cohort study is to evaluate current surveillance strategies after primary resection of pancreatic ductal adenocarcinoma (PDAC) in the Netherlands, with regard to the detection, treatment and survival of PDAC recurrence.

Conditions

• Pancreatic Ductal Adenocarcinoma
• Pancreatic Cancer
• Pancreas Cancer
• PDAC

Sponsors & Collaborators

• Amsterdam UMC, location VUmc

  collaborator OTHER

• Erasmus Medical Center

  collaborator OTHER

• Catharina Ziekenhuis Eindhoven

  collaborator OTHER

• Radboud University Medical Center

  collaborator OTHER

• University Medical Center Groningen

  collaborator OTHER

• Jeroen Bosch Ziekenhuis

  collaborator OTHER

• Leiden University Medical Center

  collaborator OTHER

• Maastricht University Medical Center

  collaborator OTHER

• Maasstad Hospital

  collaborator OTHER

• Amphia Hospital

  collaborator OTHER

• Onze Lieve Vrouwe Gasthuis

  collaborator OTHER

• Reinier de Graaf Groep

  collaborator OTHER

• Isala

  collaborator OTHER

• St. Antonius Hospital

  collaborator OTHER

• UMC Utrecht

  lead OTHER

Principal Investigators

• I. Quintus Molenaar, MD, PhD · UMC Utrecht

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2014-01-01

Primary Completion

2023-07-01

Completion

2023-07-01

Countries

• Netherlands

Study Locations